A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Clinical trial NCT04672460 · COMPLETED

Trial details

NCT number: NCT04672460
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Solid Tumors Ovarian Cancer Breast Cancer Prostate Cancer NSCLC Pancreatic Cancer Colorectal Cancer

Start date: 2020-12-21
Primary completion: 2022-02-04
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.